Allianz Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-70,621
| Closed | -$1.42M | – | 2319 |
|
|
2018
Q4 | $1.42M | Sell |
70,621
-14,756
| -17% | -$297K | ﹤0.01% | 1572 |
|
|
2018
Q3 | $2.12M | Buy |
85,377
+6,311
| +8% | +$157K | ﹤0.01% | 1551 |
|
|
2018
Q2 | $2.17M | Sell |
79,066
-371
| -0.5% | -$10.2K | ﹤0.01% | 1495 |
|
|
2018
Q1 | $2.45M | Buy |
79,437
+11,271
| +17% | +$347K | ﹤0.01% | 1440 |
|
|
2017
Q4 | $2.44M | Buy |
68,166
+10,344
| +18% | +$370K | ﹤0.01% | 1477 |
|
|
2017
Q3 | $1.59M | Buy |
57,822
+1,537
| +3% | +$42.3K | ﹤0.01% | 1563 |
|
|
2017
Q2 | $1.49M | Buy |
56,285
+5,672
| +11% | +$150K | ﹤0.01% | 1571 |
|
|
2017
Q1 | $1.05M | Buy |
+50,613
| New | +$1.05M | ﹤0.01% | 1708 |
|